EXAGEN INC. Basic Shares Outstanding (Weighted Average)
EXAGEN INC. (XGN) reported Basic Shares Outstanding (Weighted Average) of 24.16 million shares for the 3-month period ending 2026-06-30, per its 10-Q filed 2026-08-04.
Financial Statements › Income Statement › Earnings Per Share
us-gaap:WeightedAverageNumberOfSharesOutstandingBasic · last filed 2026-08-04
- EXAGEN INC. weighted average number of shares outstanding, basic for the quarter ending 2026-06-30 was 24.16M shares, a 14.60% increase year-over-year.
- EXAGEN INC. weighted average number of shares outstanding, basic for the quarter ending 2026-03-31 was 23.85M shares, a 28.55% increase year-over-year.
- EXAGEN INC. weighted average number of shares outstanding, basic for the quarter ending 2025-12-31 was 23.60M shares, a 28.04% increase year-over-year.
- EXAGEN INC. weighted average number of shares outstanding, basic for the quarter ending 2025-09-30 was 22.94M shares, a 25.67% increase year-over-year.
- EXAGEN INC. weighted average number of shares outstanding, basic for fiscal 2025 was 21.56M shares, a 18.43% increase from fiscal 2024.
- EXAGEN INC. weighted average number of shares outstanding, basic for fiscal 2024 was 18.20M shares, a 2.96% increase from fiscal 2023.
- EXAGEN INC. weighted average number of shares outstanding, basic for fiscal 2023 was 17.68M shares, a 3.50% increase from fiscal 2022.
- EXAGEN INC. weighted average number of shares outstanding, basic for fiscal 2022 was 17.08M shares, a 6.95% increase from fiscal 2021.
| Period end | Weighted Average Number of Shares Outstanding, Basic 3 month | Weighted Average Number of Shares Outstanding, Basic 6 month | Weighted Average Number of Shares Outstanding, Basic 9 month | Weighted Average Number of Shares Outstanding, Basic 12 month |
|---|---|---|---|---|
| 2026-06-30 | 24.16M shares 10-Q · filed 2026-08-04 | 24.01M shares 10-Q · filed 2026-08-04 | 23.87M shares derived: average of 3 quarters · filed 2026-08-04 | 23.64M shares derived: average of 4 quarters · filed 2026-08-04 |
| 2026-03-31 | 23.85M shares 10-Q · filed 2026-05-11 | 23.73M shares derived: average of 2 quarters · filed 2026-05-11 | 23.46M shares derived: average of 3 quarters · filed 2026-05-11 | 22.87M shares derived: average of 4 quarters · filed 2026-08-04 |
| 2025-12-31 | 23.60M shares derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-10 | 23.27M shares derived: average of 2 quarters · filed 2026-03-10 | 22.54M shares derived: average of 3 quarters · filed 2026-08-04 | 21.56M shares 10-K · filed 2026-03-10 |
| 2025-09-30 | 22.94M shares 10-Q · filed 2025-11-04 | 22.01M shares derived: average of 2 quarters · filed 2026-08-04 | 20.88M shares 10-Q · filed 2025-11-04 | 20.25M shares derived: average of 4 quarters · filed 2026-08-04 |
| 2025-06-30 | 21.09M shares 10-Q · filed 2026-08-04 | 19.83M shares 10-Q · filed 2026-08-04 | 19.36M shares derived: average of 3 quarters · filed 2026-08-04 | 19.08M shares derived: average of 4 quarters · filed 2026-08-04 |
| 2025-03-31 | 18.56M shares 10-Q · filed 2026-05-11 | 18.49M shares derived: average of 2 quarters · filed 2026-05-11 | 18.41M shares derived: average of 3 quarters · filed 2026-05-11 | 18.36M shares derived: average of 4 quarters · filed 2026-05-11 |
| 2024-12-31 | 18.43M shares derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-10 | 18.34M shares derived: average of 2 quarters · filed 2026-03-10 | 18.29M shares derived: average of 3 quarters · filed 2026-03-10 | 18.20M shares 10-K · filed 2026-03-10 |
| 2024-09-30 | 18.25M shares 10-Q · filed 2025-11-04 | 18.22M shares derived: average of 2 quarters · filed 2025-11-04 | 18.13M shares 10-Q · filed 2025-11-04 | 18.05M shares derived: average of 4 quarters · filed 2025-11-04 |
| 2024-06-30 | 18.18M shares 10-Q · filed 2025-07-29 | 18.06M shares 10-Q · filed 2025-07-29 | 17.99M shares derived: average of 3 quarters · filed 2025-07-29 | 17.91M shares derived: average of 4 quarters · filed 2025-07-29 |
| 2024-03-31 | 17.94M shares 10-Q · filed 2025-05-05 | 17.89M shares derived: average of 2 quarters · filed 2025-05-05 | 17.82M shares derived: average of 3 quarters · filed 2025-05-05 | 17.78M shares derived: average of 4 quarters · filed 2025-05-05 |
| 2023-12-31 | 17.84M shares derived: 10-K 12 month − 10-Q 9 month · filed 2025-03-11 | 17.77M shares derived: average of 2 quarters · filed 2025-03-11 | 17.73M shares derived: average of 3 quarters · filed 2025-03-11 | 17.68M shares 10-K · filed 2025-03-11 |
| 2023-09-30 | 17.69M shares 10-Q · filed 2024-11-12 | 17.67M shares derived: average of 2 quarters · filed 2024-11-12 | 17.63M shares 10-Q · filed 2024-11-12 | 17.52M shares derived: average of 4 quarters · filed 2024-11-12 |
| 2023-06-30 | 17.66M shares 10-Q · filed 2024-08-05 | 17.59M shares 10-Q · filed 2024-08-05 | 17.46M shares derived: average of 3 quarters · filed 2024-08-05 | 17.36M shares derived: average of 4 quarters · filed 2024-08-05 |
| 2023-03-31 | 17.53M shares 10-Q · filed 2024-05-13 | 17.36M shares derived: average of 2 quarters · filed 2024-05-13 | 17.27M shares derived: average of 3 quarters · filed 2024-05-13 | 17.22M shares derived: average of 4 quarters · filed 2024-05-13 |
| 2022-12-31 | 17.20M shares derived: 10-K 12 month − 10-Q 9 month · filed 2024-03-18 | 17.14M shares derived: average of 2 quarters · filed 2024-03-18 | 17.11M shares derived: average of 3 quarters · filed 2024-03-18 | 17.08M shares 10-K · filed 2024-03-18 |
| 2022-09-30 | 17.08M shares 10-Q · filed 2023-11-13 | 17.07M shares derived: average of 2 quarters · filed 2023-11-13 | 17.04M shares 10-Q · filed 2023-11-13 | 17.03M shares derived: average of 4 quarters · filed 2023-11-13 |
| 2022-06-30 | 17.06M shares 10-Q · filed 2023-08-07 | 17.03M shares 10-Q · filed 2023-08-07 | 17.01M shares derived: average of 3 quarters · filed 2023-08-07 | 16.99M shares derived: average of 4 quarters · filed 2023-08-07 |
| 2022-03-31 | 16.99M shares 10-Q · filed 2023-05-15 | 16.99M shares derived: average of 2 quarters · filed 2023-05-15 | 16.97M shares derived: average of 3 quarters · filed 2023-05-15 | 16.96M shares derived: average of 4 quarters · filed 2023-05-15 |
| 2021-12-31 | 16.98M shares derived: 10-K 12 month − 10-Q 9 month · filed 2023-03-20 | 16.96M shares derived: average of 2 quarters · filed 2023-03-20 | 16.95M shares derived: average of 3 quarters · filed 2023-03-20 | 15.97M shares 10-K · filed 2023-03-20 |
| 2021-09-30 | 16.95M shares 10-Q · filed 2022-11-21 | 16.94M shares derived: average of 2 quarters · filed 2022-11-21 | 15.64M shares 10-Q · filed 2022-11-21 | 14.87M shares derived: average of 4 quarters · filed 2022-11-21 |
| 2021-06-30 | 16.93M shares 10-Q/A · filed 2022-11-21 | 14.95M shares 10-Q/A · filed 2022-11-21 | 14.17M shares derived: average of 3 quarters · filed 2022-11-21 | 13.79M shares derived: average of 4 quarters · filed 2022-11-21 |
| 2021-03-31 | 12.94M shares 10-Q · filed 2022-05-11 | 12.80M shares derived: average of 2 quarters · filed 2022-05-11 | 12.75M shares derived: average of 3 quarters · filed 2022-05-11 | 12.72M shares derived: average of 4 quarters · filed 2022-05-11 |
| 2020-12-31 | 12.65M shares derived: 10-K 12 month − 10-Q 9 month · filed 2022-03-22 | 12.65M shares derived: average of 2 quarters · filed 2022-03-22 | 12.64M shares derived: average of 3 quarters · filed 2022-03-22 | 12.63M shares 10-K · filed 2022-03-22 |
| 2020-09-30 | 12.64M shares 10-Q · filed 2021-11-10 | 12.64M shares derived: average of 2 quarters · filed 2021-11-10 | 12.63M shares 10-Q · filed 2021-11-10 | |
| 2020-06-30 | 12.64M shares 10-Q · filed 2021-08-09 | 12.62M shares 10-Q · filed 2021-08-09 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Freenome, Inc. (FRNM) | United States | $0.143B | |
| BIODESIX INC (BDSX) | United States | $0.312B | |
| SERA PROGNOSTICS, INC. (SERA) | United States | $0.062B | -5.75 |
| AMERICAN SHARED HOSPITAL SERVICES (AMS) | United States | $0.010B | -5.64 |
| Advanced Biomed Inc. (ADVB) | $0.009B | ||
| Aclarion, Inc. (ACON) | United States | $0.008B | |
| BioNexus Gene Lab Corp (BGLC) | $0.004B | ||
| Fulgent Genetics, Inc. (FLGT) | United States | $0.593B | -6.70 |
| Lumexa Imaging Holdings, Inc. (LMRI) | United States | $0.951B | |
| CASTLE BIOSCIENCES INC (CSTL) | United States | $1.074B | -37.45 |